Abbate JL, Becquart P, Leroy E, et al. Exposure to Ebola virus and risk for infection with malaria parasites, rural Gabon. Emerg Infect Dis 2019 (published online Dec 12)
Adolfi A, Poulton B, Anthousi A, et al. Functional genetic validation of key genes conferring insecticide resistance in the major African malaria vector, Anopheles gambiae. Proc Natl Acad Sci USA (published online Dec 4)
Ahmadpour E, Foroutan-Rad M, Majidiani H, et al. Transfusion-transmitted malaria: a systematic review and meta-analysis. Open Forum Infect Dis 2019 (published online Jun 11)
Ahmed R, Poespoprodjo JR, Syafruddin D, et al. Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised open-label, superiority trial. Lancet Infect Dis 2019 (published online Jul 25)
Akech S, Chepkirui M, Ogero M, et al. The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in western Kenya. Clin Infect Dis 2019 (published online Aug 26)
Amoah LE, Donu D, Abuaku B, et al. Probing the composition of Plasmodium species contained in malaria infections in the Eastern Region of Ghana. BMC Public Health 2019 Dec 2;19(1617)
Arzika AM, Maliki R, Boubacar N, et al. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: a cluster-randomized, placebo-controlled trial. PLoS Med 2019 (published online Jun 25)
Bahati YL, Delanghe J, Balaluka GB, et al. Asymptomatic submicroscopic Plasmodium infection is highly prevalent and is associated with anemia in children younger than 5 years in south Kivu/Democratic Republic of Congo. Am J Trop Med Hyg 2020 (published online Mar 2)
Byakika-Kibwika P, Ssenyonga R, Lamorde M, et al. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous artesunate or quinine plus dihydroartemisinin-piperaquine. BMC Infect Dis 2019 Dec 3;29:1025
Commons RJ, Simpson JA, Thriemer K, et al. The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: a systematic review and individual patient data meta-analysis. PLOS Med 2019 Oct 4;16(10):e1002928
de Abreu FVS, dos Santos E, Mello ARL, et al. Howler monkeys are the reservoir of malarial parasites causing zoonotic infections in the Atlantic forest of Rio de Janeiro. PLOS Negl Trop Dis 2019 Dec 9;13(12):e0007906
Desai M, Samels A, Odongo W, et al. Impact of intermittent mass testing and treatment of incidence of malaria infection in a high transmission area of western Kenya. Am J Trop Med Hyg 2020 (published online Apr 27)
Dini S, Douglas NM, Poespoprodjo JR, et al. The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia; a retrospective cohort study. BMC Med 2020 (published online Feb 20)
EDCTP. International research partnership and European & Developing Countries Clinical Trial Partnership (EDCTP) to invest [Euros]44m in next-generation antimalarials to combat drug-resistant malaria in Africa. EDCTP 2020 (published online Mar 3)
Eldh M, Hammar U, Arnot D, et al. Multiplicity of asymptomatic Plasmodium falciparum infections and risk of clinical malaria: a systematic review and pooled analysis of individual participant data. J Infect Dis 2019 (published online Oct 4)
Hamilton WL, Amato R, van der Pluijm RW, et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect Dis 2019 (published online Jul 22)
Hart JD, Samikwa L, Sikina F, et al. Effects of biannual azithromycin mass drug administration on malaria in Malawian children: a cluster-randomized trial. Am J Trop Med Hyg 2020 (published online Apr 27)
Haston JC, Hwang J, Tan KR. Guidance for using tafenoquine for prevention and antirelapse therapy for malaria — United States, 2019. MMWR 2019 Nov 22;68(46):1062-8
Jongo SA, Church LWP, Mtoro AT, et al. Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ vaccine in Tanzanian adults. Clin Infect Dis 2019 (published online Nov 29)
